Mallinckrodt Completes Acquisition of Stratatech Corporation, a Regenerative Medicine Company Focused on Proprietary Therapeutics for Substituting Human Skin

CHESTERFIELD, United Kingdom, August 31, 2016 / PRNewswire / – Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced that it has completed the acquisition of Stratatech Corporation, a privately-held regenerative medicine company focused on the development of proprietary and proprietary skin replacement products. Development products include StrataGraft® …

Read More »

Allergan acquires medical dermatology and aesthetic medicine company Anterios to expand its neurotoxin pipeline

DUBLIN and NEW YORK, Jan. 7, 2016 / PRNewswire / – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the acquisition of Anterios, Inc., a clinical-stage biopharmaceutical company developing a novel delivery system generation and prescription botulinum toxin products. Under the agreement, Allergan acquired Anterios for an …

Read More »

Food and drug regulations do not protect consumers

There seems to be no end to the chain of producing so-called “therapeutic” products promoted to trusted consumers by companies willing to make untested claims. The latest is Souvenaid®, a product promoted as a “medical food” for “the treatment of mild Alzheimer’s disease” by its manufacturer, Nutricia Australia Pty Ltd. …

Read More »